Sample sizes are frequently small, and long-term follow-up data is often lacking
A3: Research typically characterizes IGF-1 and its analogues, including IGF-1 LR3, as supporting hyperplasia (increased cell number) rather than direct hypertrophy (increased cell size)
Here's what scientists say you can do about it
In the current study, the dose range was 23 g/day and there was no significant dose-dependence from l-carnitine efficacy on BMI in T2DM patients, so the lower dose of 2 g/day was selected as recommended dose
When GLP-1 stops, weight returns faster than expected The most comprehensive evidence so far comes from a large meta-analysis in The BMJ
[DOI] [PMC free article] [PubMed] [Google Scholar] 22.Murphy R., Plank L.D., Clarke M.G., Evennett N.J., Tan J., Kim D.D.W., Cutfield R., Booth M.W.C